Tag archive for ‘Omecamtiv mecarbil results in COSMIC-HF’
Cytokinetics: Results of COSMIC HF Published in The Lancet; Phase 3 GALACTIC HF Trial Has Started (CYTK, Buy, $12.00)
Key Points Results from the COSMIC HF phase 2 trial of omecamtiv mecarbil support the hypothesis that it improves heart function and (very importantly) reverses structural damage in patients with heart failure. Side effects are comparable to placebo. If these results are replicated in the GALACTIC-HF phase 3 trial, I believe that omecamtiv mecarbil has […]